Goldman Sachs’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Buy |
|
|||||
|
2025
Q1 | $741K | Sell |
|
|||||
|
2024
Q4 | $1.17M | Sell |
|
|||||
|
2024
Q3 | $1.1M | Sell |
|
|||||
|
2024
Q2 | $1.34M | Buy |
|
|||||
|
2024
Q1 | $981K | Sell |
|
|||||
|
2023
Q4 | $1.56M | Sell |
|
|||||
|
2023
Q3 | $3.52M | Buy |
|
|||||
|
2023
Q2 | $4.85M | Buy |
|
|||||
|
2023
Q1 | $3.24M | Buy |
|
|||||
|
2022
Q4 | $1.3M | Sell |
|
|||||
|
2022
Q3 | $3.05M | Sell |
|
|||||
|
2022
Q2 | $9.05M | Buy |
|
|||||
|
2022
Q1 | $5.51M | Sell |
|
|||||
|
2021
Q4 | $11.8M | Buy |
|
|||||
|
2021
Q3 | $6.41M | Buy |
|
|||||
|
2021
Q2 | $5.36M | Buy |
|
|||||
|
2021
Q1 | $1.54M | Buy |
|
|||||
|
2020
Q4 | $932K | Buy |
|
|||||
|
2020
Q3 | $322K | Buy |
|